Cefotetan: Difference between revisions
m (Protected "Cefotetan": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 26: | Line 26: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Cefotetan''' is an injectable [[antibiotic]] of the [[cephamycin]] type for prophylaxis and treatment of [[bacterial infection]]s. It is often grouped together with second-generation [[cephalosporin]]s and has a similar antibacterial spectrum, but with additional anti-anaerobe converage. | '''Cefotetan''' is an injectable [[antibiotic]] of the [[cephamycin]] type for prophylaxis and treatment of [[bacterial infection]]s. It is often grouped together with second-generation [[cephalosporin]]s and has a similar antibacterial spectrum, but with additional anti-anaerobe converage. | ||
| Line 39: | Line 39: | ||
[[category:cephalosporin antibiotics]] | [[category:cephalosporin antibiotics]] | ||
[[th:เซโฟตีแทน]] | [[th:เซโฟตีแทน]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WS}} | {{WS}} | ||
Revision as of 23:36, 8 August 2012
| File:Cefotetan.svg | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C17H17N7O8S4 |
| Molar mass | 575.623 g/mol |
|
WikiDoc Resources for Cefotetan |
|
Articles |
|---|
|
Most recent articles on Cefotetan |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Cefotetan at Clinical Trials.gov Clinical Trials on Cefotetan at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Cefotetan
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Cefotetan Discussion groups on Cefotetan Directions to Hospitals Treating Cefotetan Risk calculators and risk factors for Cefotetan
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Cefotetan |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Cefotetan is an injectable antibiotic of the cephamycin type for prophylaxis and treatment of bacterial infections. It is often grouped together with second-generation cephalosporins and has a similar antibacterial spectrum, but with additional anti-anaerobe converage.
Cefotetan was developed by Yamanouchi. It is marketed outside Japan by AstraZeneca with the brand names Apatef and Cefotan.
External links
- Cefotan official web site run by AstraZeneca US
- Cefotetan entry in RxList
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cephalosporin antibiotics